Inactive Instrument
LAVA Therapeutics Share Price
Stocks
LVTX
NL0015000AG6
Biotechnology & Medical Research
| 1 day | -3.87% |
| 1 year | 1.44 |  | 1.82 |
| 3 years | 0.85 | | 6.47 |
| 5 years | 0.85 | | 8 |
| 10 years | 0.85 | | 17.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 09/11/2021 | |
Robin Hume
LAW | General Counsel | - | 15/05/2023 |
| Human Resources Officer | - | 09/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Kapil Dhingra
CHM | Chairman | 66 | 22/02/2021 |
Karen Wilson
BRD | Director/Board Member | 63 | 01/03/2021 |
Owen Hughes
BRD | Director/Board Member | 51 | 07/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/11/25 | Issuer sale | Chief Executive Officer | 3,40,100 | 1.2929% | ||
| 13/11/25 | Issuer sale | Chief Financial Officer | 1,89,700 | 0.7211% | ||
| 13/11/25 | Issuer sale | Director | 33,390 | 0.1269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | -.--% | - | - | 4.58Cr | |
| +2.41% | -6.33% | +43.43% | +71.02% | 6.33TCr | |
| -0.15% | +7.50% | +11.01% | +73.48% | 5.49TCr | |
| +0.57% | +4.60% | +10.07% | +92.86% | 5.33TCr | |
| +0.40% | +4.47% | +26.80% | +51.78% | 4.58TCr | |
| -1.25% | +2.15% | +21.60% | +123.44% | 4.35TCr | |
| +0.04% | +5.36% | +250.84% | +921.47% | 4.02TCr | |
| +0.05% | +6.75% | +14.48% | +56.75% | 3.35TCr | |
| +1.19% | -5.84% | +27.86% | -0.65% | 2.37TCr | |
| -0.38% | +5.68% | +36.43% | +27.54% | 2.38TCr | |
| Average | -0.10% | +0.33% | +49.17% | +157.52% | 4.24TCr | |
| Weighted average by Cap. | +0.42% | +0.55% | +47.55% | +159.26% |
Employees
10
